120 Chemin de la Rive
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees:
|Mr. Adam Miron||Co-Founder & Director||184.9k||N/A||1984|
|Mr. Roch Vaillancourt||Gen. Counsel||354.04k||N/A||N/A|
|Mr. Michael P. Monahan||Consultant||919.41k||N/A||1972|
|Mr. Scott Cooper||Pres, CEO & Director||N/A||N/A||N/A|
|Mr. Curtis G. Solsvig III||Acting Chief Financial Officer||N/A||N/A||1955|
|Jennifer Smith||Mang. of Financial Reporting & Investor Relations||N/A||N/A||N/A|
|Mr. Max Cyr||Director of Customer Experience & Compliance||N/A||N/A||N/A|
|Ms. Isabelle Dominique Robillard||VP of Communication||N/A||N/A||N/A|
|Ms. Sonia Isabel||Vice-Pres of Sales||N/A||N/A||N/A|
|Mr. Guillaume Jouet||Chief People & Culture Officer||N/A||N/A||N/A|
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada.
HEXO Corp.’s ISS Governance QualityScore as of February 1, 2022 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder Rights: 4; Compensation: 8.